Erickson Patricia A, Andreotti Gabriella, Remigio Richard V, Ward Mary H, Parks Christine G, Sandler Dale P, Albert Paul S, Barry Kathryn Hughes, Hofmann Jonathan N, Beane Freeman Laura E
Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
Int J Hyg Environ Health. 2025 Jul;268:114615. doi: 10.1016/j.ijheh.2025.114615. Epub 2025 Jun 28.
Carbaryl is a common carbamate insecticide in the United States (USA). Previous epidemiologic investigations, including within the Agricultural Health Study (AHS), have suggested potential associations between carbaryl use and cancer risk. The AHS is a prospective cohort study of licensed pesticide applicators in North Carolina (NC) and Iowa (IA), USA. Information on lifetime pesticide use was reported at enrollment (1993-1997) and follow-up (1999-2005). We evaluated cancer risks associated with ever- and intensity-weighted lifetime days (IWLD) of carbaryl use. Among 52,625 applicators, 8713 incident cancer cases were identified from linkages with state cancer registries through 2014 (NC) or 2017 (IA). We used Poisson regression to estimate rate ratios (RR) and 95 % confidence intervals (CI), controlling for confounders, and evaluated lagged exposures. Approximately 51 % of applicators reported using carbaryl. Increasing IWLD of carbaryl use was associated with increased stomach cancer risk (third tertile vs. never use; RR = 2.07, 95 % CI: 1.05-4.07, p-trend = 0.02), persisting when exposure was lagged by 5-years (RR = 2.20, 95 % CI: 1.12-4.33). We noted elevated risks of esophageal (RR = 1.52, 95 % CI: 1.01-2.27) and tongue (RR = 1.91, 95 % CI: 0.95-3.81) cancers with ever-use. There was an increased risk of aggressive prostate cancer when carbaryl exposure was lagged by 30 years (RR = 1.56, 95 % CI: 1.18-2.08, p-trend = 0.002). This is the largest and most comprehensive prospective evaluation of carbaryl and cancer risk to date. We provide novel evidence of associations between carbaryl exposure and specific cancers. There is a need for additional studies to confirm these findings and to elucidate the biological mechanisms underlying the observed associations.
西维因是美国一种常见的氨基甲酸酯类杀虫剂。包括农业健康研究(AHS)在内的以往流行病学调查表明,使用西维因与癌症风险之间可能存在关联。AHS是一项针对美国北卡罗来纳州(NC)和爱荷华州(IA)有执照的农药施用者的前瞻性队列研究。在入组时(1993 - 1997年)和随访时(1999 - 2005年)报告了终生农药使用情况。我们评估了与西维因使用的终生天数(IWLD)及强度加权终生天数相关的癌症风险。在52,625名施用者中,通过与州癌症登记处的关联,到2014年(NC)或2017年(IA)共确定了8713例新发癌症病例。我们使用泊松回归来估计率比(RR)和95%置信区间(CI),控制混杂因素,并评估滞后暴露情况。约51%的施用者报告使用过西维因。西维因使用的IWLD增加与胃癌风险增加相关(第三三分位数与从未使用相比;RR = 2.07,95% CI:1.05 - 4.07,p趋势 = 0.02),当暴露滞后5年时这种关联依然存在(RR = 2.20,95% CI:1.12 - 4.33)。我们注意到曾经使用西维因会使食管癌(RR = 1.52,95% CI:1.01 - 2.27)和舌癌(RR = 1.91,95% CI:0.95 - 3.81)的风险升高。当西维因暴露滞后30年时,侵袭性前列腺癌的风险增加(RR = 1.56,95% CI:1.18 - 2.08,p趋势 = 0.002)。这是迄今为止对西维因与癌症风险进行的最大规模、最全面的前瞻性评估。我们提供了西维因暴露与特定癌症之间关联的新证据。需要进一步的研究来证实这些发现,并阐明所观察到的关联背后的生物学机制。